Deccan Cements Limited has informed BSE of a board and audit committee meeting on 12 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes 01 October to 14 November 2026.
Infomerics withdrew its rating on Deccan Cements' proposed NCD issue after the proposal was dropped. The earlier August 2026 action was a downgrade to IVR BB+/Negative.
Deccan Cements Limited held its 46th Annual General Meeting on 29th September 2026. The meeting transacted ordinary and special business, including financial statement adoption and dividend approval.
Deccan Cements Limited scheduled its 46th Annual General Meeting for September 29, 2026, and submitted the accompanying 46th Annual Report for the financial year 2025-26.
Deccan Cements clarified that Infomerics Valuation and Rating Limited conducted a rating review for a previously withdrawn Rs. 50 Crore NCD proposal, despite the company's request.
Deccan Cements filed its Monitoring Agency report for the quarter ended June 30, 2026, confirming the full utilization of Rs. 102.99 Crore raised via CCDs.
Deccan Cements received a credit rating update from CARE Ratings, with long-term bank facilities downgraded to CARE BBB/Stable and short-term ratings reaffirmed at CARE A3+.
Deccan Cements will hold a Board Meeting on August 12, 2026, to consider quarterly financial results and dividends. Trading window is currently closed until August 14, 2026.
CRISIL downgraded Deccan Cements' long-term rating to 'CRISIL BB/Stable' (Issuer Not Cooperating). The company noted that all term loans were already repaid before the rating action.
Deccan Cements allotted convertible and non-convertible debentures totaling ₹143.04 Crore. This capital raise involves both secured and unsecured instruments.
Deccan Cements shareholders approved the issuance of Compulsorily Convertible Debentures via postal ballot. The special resolution passed with 99.99% votes in favour.
Infomerics assigned a long-term rating of IVR BBB-/Negative (ISSUER NOT COOPERATING*) to Deccan Cements. The company had withdrawn the proposed NCD issuance before the review.
Deccan Cements recommended a final dividend of Re. 0.50 per equity share for FY 2025-26. The distribution is subject to shareholder approval at the upcoming AGM.
Deccan Cements appointed M. Bhaskara Rao & Co. as Internal Auditors and Aruna Prasad & Co. as Cost Auditors. Both appointments are effective from April 2026.
Deccan Cements reported audited FY26 results and recommended a 10% dividend of Re.0.50 per share. The board also appointed new cost and internal auditors for FY27.
Deccan Cements issued a corrigendum for its ₹102.99 Crore CCD preferential issue. Funds will repay secured term loans, with CARE Ratings appointed as monitoring agency.
Deccan Cements will hold a board meeting on May 29, 2026. Directors will consider FY2025-26 audited financial results and a final dividend recommendation.
Deccan Cements is seeking shareholder approval to raise ₹103 Crore via Compulsorily Convertible Debentures. The funds will be used for repaying existing term loans.